• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities.

作者信息

Jiao Xiaofei, Wang Ya, Liu Dan, Zeng Shaoqing, Chi Jianhua, Li Ruyuan, Yu Yang, Yu Ruidi, Wang Siyuan, Yuan Yuan, Gao Yue, Xu Sen, Li Chunrui, Gao Qinglei

机构信息

National Medical Center for Major Public Health Events, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

出版信息

Clin Transl Med. 2020 Dec;10(8):e235. doi: 10.1002/ctm2.235.

DOI:10.1002/ctm2.235
PMID:33377641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7724098/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/7724098/df6c9fcbcfab/CTM2-10-e235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/7724098/df6c9fcbcfab/CTM2-10-e235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3163/7724098/df6c9fcbcfab/CTM2-10-e235-g001.jpg

相似文献

1
A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities.一项针对不同疾病严重程度的新冠肺炎患者糖皮质激素治疗的真实世界研究。
Clin Transl Med. 2020 Dec;10(8):e235. doi: 10.1002/ctm2.235.
2
Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK.美国和英国真实世界数据库中巨细胞动脉炎患者累积口服糖皮质激素使用相关风险
Rheumatol Ther. 2018 Dec;5(2):327-340. doi: 10.1007/s40744-018-0112-8. Epub 2018 May 11.
3
Early predictors for mechanical ventilation in COVID-19 patients.新型冠状病毒肺炎患者机械通气的早期预测指标。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963017. doi: 10.1177/1753466620963017.
4
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia.接受慢性羟氯喹治疗的患者中的 COVID-19 肺炎：三例 COVID-19 肺炎病例
Case Rep Infect Dis. 2020 Oct 22;2020:8822753. doi: 10.1155/2020/8822753. eCollection 2020.
5
Expressions of SAA, CRP, and FERR in different severities of COVID-19.SAA、CRP 和 FERR 在不同 COVID-19 严重程度下的表达。
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11386-11394. doi: 10.26355/eurrev_202011_23631.
6
Gene expression profiling of coronary artery disease and its relation with different severities.冠状动脉疾病的基因表达谱分析及其与不同严重程度的关系。
J Genet. 2018 Sep;97(4):853-867.
7
Validation of a modified table to map the 1998 Abbreviated Injury Scale to the 2008 scale and the use of adjusted severities.一种用于将1998年简略损伤量表映射到2008年量表并使用调整后严重程度的改良表格的验证。
J Trauma. 2011 Dec;71(6):1829-34. doi: 10.1097/TA.0b013e31823cc5c5.
8
Correlations of Online Search Engine Trends With Coronavirus Disease (COVID-19) Incidence: Infodemiology Study.在线搜索引擎趋势与冠状病毒病（COVID-19）发病的相关性：信息流行病学研究。
JMIR Public Health Surveill. 2020 May 21;6(2):e19702. doi: 10.2196/19702.
9
A review of the prevalence of COVID-19 in the Arab world.阿拉伯世界新冠病毒病（COVID-19）流行情况综述。
J Infect Dev Ctries. 2020 Nov 30;14(11):1238-1245. doi: 10.3855/jidc.13270.
10
The relationship between mental disorders and physical severities in patients with acute myocardial infarction.急性心肌梗死患者精神障碍与身体严重程度之间的关系。
Jpn Circ J. 1983 Jun;47(6):723-8. doi: 10.1253/jcj.47.723.

引用本文的文献

1
Effect of Methylprednisolone on Mortality and Clinical Courses in Patients with Severe COVID-19: A Propensity Score Matching Analysis.甲泼尼龙对重症新型冠状病毒肺炎患者死亡率及临床病程的影响：一项倾向评分匹配分析
Infect Dis Immun. 2023 Jan;3(1):20-28. doi: 10.1097/ID9.0000000000000076. Epub 2022 Oct 21.
2
Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.2019年冠状病毒病（COVID-19）中使用皮质类固醇的疗效和安全性：一项系统评价和荟萃分析。
Infect Dis Ther. 2021 Dec;10(4):2447-2463. doi: 10.1007/s40121-021-00518-3. Epub 2021 Aug 13.

本文引用的文献

1
Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients.皮质类固醇治疗与 COVID-19 患者中 SARS-CoV-2 清除的延迟有关。
Eur J Pharmacol. 2020 Dec 15;889:173556. doi: 10.1016/j.ejphar.2020.173556. Epub 2020 Sep 15.
2
Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.患有新冠肺炎及其他病症的重症患者体内的细胞因子水平
JAMA. 2020 Sep 3;324(15):1565-7. doi: 10.1001/jama.2020.17052.
3
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
糖皮质激素治疗 COVID-19 肺炎患者的临床疗效：一项单中心经验。
Biomed Pharmacother. 2020 Oct;130:110529. doi: 10.1016/j.biopha.2020.110529. Epub 2020 Jul 28.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
5
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019（COVID-19）的病理生理学、传播、诊断和治疗：综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
6
A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia.一项关于甲泼尼龙治疗COVID-19重症肺炎患者的回顾性队列研究。
Signal Transduct Target Ther. 2020 Apr 28;5(1):57. doi: 10.1038/s41392-020-0158-2.
7
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.精准皮质类固醇治疗对重症2019新型冠状病毒肺炎的潜在益处。
Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.
8
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
9
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).COVID-19 患者的皮质类固醇治疗。
Med J Aust. 2020 May;212(9):416-420. doi: 10.5694/mja2.50577. Epub 2020 Apr 8.
10
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.